Chris Dall | News Reporter | CIDRAP NewsMay 22, 2020The largest study to date on the use of hydroxychloroquine and chloroquine finds no benefit, but the drugs were associated with a higher risk of hospital death and serious heart rhythm complications.
Malaria drugs tied to risk of death, heart problems in COVID-19 patients
Published in COVID-19
More from COVID-19More posts in COVID-19 »
- During pandemic, ivermectin use rose 10-fold, hydroxychloroquine use doubled, study reveals
- ACIP postponement, shelving of CDC vaccine campaigns stir fears
- US flu still high, COVID low but elevated in some areas, RSV declining, CDC says
- Data suggest Paxlovid doesn’t reduce severe COVID in older, vaccinated adults